Literature DB >> 22424021

Natural history of exercise function in patients with Ebstein anomaly: A serial study.

Alaina K Kipps1, Dionne A Graham, Erik Lewis, Gerald R Marx, Puja Banka, Jonathan Rhodes.   

Abstract

BACKGROUND: The clinical manifestations of Ebstein anomaly (EA) vary greatly; criteria for surgical intervention remain undefined. Decisions regarding surgical intervention in asymptomatic/mildly symptomatic patients would be helpfully informed by a detailed, quantitative understanding of the natural history of exercise intolerance in these patients. However, past studies of exercise function in EA have been of a cross-sectional, rather than a serial, nature. We, therefore, analyzed serial cardiopulmonary exercise (CPX) tests from patients with unrepaired EA to better appreciate the natural history of their exercise function.
METHODS: All patients with EA who had had at least 2 CPX tests, separated by at least 6 months, between November 2002 and October 2010 were identified. Patients with prior tricuspid valve surgery were excluded from the study.
RESULTS: Cardiopulmonary exercise data from 23 patients (64 CPX tests; 2.8 ± 1.0 tests/patient) were analyzed. The median time interval between the first and last CPX tests was 3.3 (range, 0.6-7.3) years. The percentage of predicted peak oxygen consumption declined slowly (1.87 ± 8.04 percentage points/y) during the follow-up period. The decline was more pronounced (3.04 ± 6.78 percentage points/y) in patients <18 years old. On multivariate modeling, only the change in oxygen pulse at peak exercise (a surrogate for forward stroke volume) and the change in peak heart rate over time emerged as statistically significant correlates of the change in percentage of predicted peak oxygen consumption.
CONCLUSION: The exercise function of patients with EA tends to deteriorate over time. This deterioration appears to be related to a progressive decline in their ability to augment their forward stroke volume and heart rate during exercise. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22424021     DOI: 10.1016/j.ahj.2011.12.006

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Ebstein anomaly: assessment, management, and timing of intervention.

Authors:  Puneeta Arya; Rebecca Beroukhim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-10

2.  Dynamic interactions of gas exchange, body mass, and progressive exercise in children.

Authors:  Dan M Cooper; Szu-Yun Leu; Pietro Galassetti; Shlomit Radom-Aizik
Journal:  Med Sci Sports Exerc       Date:  2014       Impact factor: 5.411

3.  Exercise Capacity After Repair of Ebstein Anomaly in Adults.

Authors:  Brandon D Morrical; Joseph A Dearani; Crystal R Bonnichsen; Nathaniel W Taggart
Journal:  Pediatr Cardiol       Date:  2019-01-30       Impact factor: 1.655

4.  Left ventricular synchrony, torsion, and recoil mechanics in Ebstein's anomaly: insights from cardiovascular magnetic resonance.

Authors:  Michael Steinmetz; Simon Usenbenz; Johannes Tammo Kowallick; Olga Hösch; Wieland Staab; Torben Lange; Shelby Kutty; Joachim Lotz; Gerd Hasenfuß; Thomas Paul; Andreas Schuster
Journal:  J Cardiovasc Magn Reson       Date:  2017-12-14       Impact factor: 5.364

5.  Haemodynamic determinants of improved aerobic capacity after tricuspid valve surgery in Ebstein anomaly.

Authors:  Alexander Egbe; William Miranda; Heidi Connolly; Joseph Dearani
Journal:  Heart       Date:  2020-10-29       Impact factor: 5.994

Review 6.  Factors influencing adaptation and performance at physical exercise in complex congenital heart diseases after surgical repair.

Authors:  P P Bassareo; L Saba; P Solla; C Barbanti; A R Marras; G Mercuro
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

7.  The modified cone reconstruction in the treatment of Ebstein's anomaly: Case reports.

Authors:  Jun-Sheng Li; Gang Chen; Jie Ma; Zi-Xing Yan; Dong-Ming Cheng; Liang Chang; Hai-Chun Zhang; Jiang-Yan Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.